Novo Nordisk, maker of the popular medications Ozempic and Wegovy, filed a lawsuit Tuesday against the pharmaceutical company Eli Lilly, accusing it of making deceptive advertising claims about its weight-loss drug Zepbound. The company has taken issue with Eli Lilly's ads that claim patients on ...
Recent coverage curated from local and regional sources.
A Michigan couple has filed a federal lawsuit against Taco Bell and produce supplier Taylor Farms, alleging they became seriously ill after …
President Donald Trump is vowing the U.S. military will soon launch strikes on Iran's Pickaxe Mountain, a fortified underground facility the…
Federal authorities executed a search warrant on Grosse Ile as part of an ongoing investigation. The search warrant was executed on Monday (…
President Donald Trump pledged to help Lebanon a lot during a White House meeting on Tuesday with the countrys leader, Joseph Aoun, who came…
Former Detroit mayor Kwame Kilpatrick is going one-on-one with Charlie Langton on "Detroit Talk City."
Ronia Shamona brings in registered nurse, Stephanie Esters, to discuss how to prepare your kids physically, mentally, and emotionally as we …
Ronia Shamona welcomes Dr. Casey Locklear to discuss the screwworm parasite warning, including how it can affect your pet, as well as the be…
Alissa Agnoli from Caring Transitions sits down with Ronia Shamona to discuss how you can make the downsizing process easier for loved ones.…
New Jersey has identified what it calls a "serious software error" that automatically registered about 6,600 non-U.S. citizens to vote. In a…
The Justice Department is investigating whether Harvard University is allowing Chinese donors to create scholarships that exclude American s…
After a difficult three days sailing through thick wildfire smoke and navigating high winds and multiple squalls, the 102nd Bayview Mackinac…
Novo Nordisk, maker of the popular medications Ozempic and Wegovy, filed a lawsuit Tuesday against the pharmaceutical company Eli Lilly, acc…
Free weekly digest. Local news that actually matters — no spam, no clickbait, easy unsubscribe.
By subscribing you agree to our privacy policy. We never sell your data.